These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37417643)

  • 1. Opioids for treating refractory dyspnea in patients with heart failure: A protocol for systematic review and meta-analysis: Retraction.
    Medicine (Baltimore); 2023 Jul; 102(27):e34401. PubMed ID: 37417643
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioids for treating refractory dyspnea in patients with heart failure: A protocol for systematic review and meta-analysis.
    Lyu J; Sun X; Chen M; Li S
    Medicine (Baltimore); 2022 Nov; 101(47):e31699. PubMed ID: 36451406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In adults with HF, opioids do not reduce refractory breathlessness (low-certainty evidence).
    Khan MS; Van Spall HGC
    Ann Intern Med; 2023 Aug; 176(8):JC88. PubMed ID: 37523697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
    Varkey B
    Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized morphine for terminal dyspnea.
    Westphal CG; Campbell ML
    Am J Nurs; 2002 May; Suppl():11-5. PubMed ID: 12006868
    [No Abstract]   [Full Text] [Related]  

  • 6. Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure--is there evidence?
    Hochgerner M; Fruhwald FM; Strohscheer I
    Wien Med Wochenschr; 2009 Dec; 159(23-24):577-82. PubMed ID: 20151346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding perspective: considering opioids in the management of dyspnoea in end-stage heart failure.
    Schlenker KA; Steiner JM
    Heart; 2023 Jun; 109(14):1048-1049. PubMed ID: 36898705
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use.
    Moran T; Zentner D; Wong J; Philip J; Smallwood N
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e334-e343. PubMed ID: 33837113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Oxycodone for Dyspnea in End-stage Heart Failure with Renal Insufficiency.
    Tanaka M; Maeba H; Senoo T; Iwasaka J; Ohkita A; Kita H; Uchitani K; Hirota Y
    Intern Med; 2018 Jan; 57(1):53-57. PubMed ID: 29033442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?
    Horton R; Rocker G; Currow D
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):92-6. PubMed ID: 20443250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story.
    Vozoris NT
    Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Vozoris NT
    Am J Respir Crit Care Med; 2021 Jan; 203(2):266-267. PubMed ID: 33022187
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Mammen MJ; Charbek E; Alexander PE; Nici L; Aaron SD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):267-269. PubMed ID: 33022179
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
    Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
    Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
    van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
    BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.
    Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA
    Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.
    Rocker G; Young J; Donahue M; Farquhar M; Simpson C
    CMAJ; 2012 Jun; 184(9):E497-504. PubMed ID: 22529167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Opioids for refractory dyspnoea in palliation].
    Aabom B; Bendstrup E; Sjøgren P; Løkke A; Shaker B; Wilcke T; Jespersen BA; Hilberg O; Marsaa K
    Ugeskr Laeger; 2020 Sep; 182(40):. PubMed ID: 33000737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
    Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
    Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All that wheezes is not obstructive pulmonary disease.
    Cydulka RK
    Ann Emerg Med; 2008 Jan; 51(1):35-6. PubMed ID: 17719693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.